TGQ-55328-96287
3 vaccinations
5 coded responses
29 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 920 / CA
- Registered
- 2021-01-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Registered in v-safe
-
2021-01-18
Dose 2 — Pfizer-BioNTech
- 2021-01-18
-
2021-01-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Diarrhea, Abdominal painAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
-
2021-02-01
Survey response — day 14, dose 2MedDRA: Gastrooesophageal reflux disease, Nausea — Feeling: GoodFree text: Nausea and acid reflux.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-04-19
- 2021-07-19
-
2021-11-15
Dose 3 — Moderna
-
2021-11-16
Survey response — days 1–6 daily, dose 3MedDRA: Swelling of eyelid — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swollen eyelidMedDRA releases: 2024-11 · check-in free text available
-
2021-11-17
Survey response — days 1–6 daily, dose 3MedDRA: Swelling of eyelid — Feeling: Good · Site: Pain, Redness, Swelling, Itching · Joint pains, Fatigue or tirednessFree text: Swollen eyelidMedDRA releases: 2024-11 · check-in free text available
-
2021-11-18
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · Fatigue or tirednessAdult check-in
-
2021-11-19
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Headache, Fatigue or tirednessAdult check-in
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
-
2022-02-16
Survey response — 3 months, dose 3MedDRA: Brain fog, Fatigue — Feeling: GoodFree text: Exhaustion, brain fogMedDRA releases: 2024-11 · check-in free text available
- 2022-05-16
-
2022-11-15
Survey response — 12 months, dose 3MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Miscarriage at 11 wks pregnancy.MedDRA releases: 2024-11 · check-in free text available
-
2022-11-15
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professionalEmergency room or emergency department visit · 1 call case(s)
- 2022-11-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-11-15 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-11-15 | Unsuccessful |
Free text
Release 3 — day 14, dose 2
Symptoms: Nausea and acid reflux.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen eyelid
Systemic reaction (other): Swollen eyelid
Release 11 — 3 months, dose 3
Symptoms: Exhaustion, brain fog
Release 12 — 12 months, dose 3
Symptoms: Miscarriage at 11 wks pregnancy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Gastrooesophageal reflux disease | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SRO | Swelling of eyelid | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release